Regulatory Practice News Today : Breaking News, Live Updates & Top Stories | Vimarsana

WASHINGTON (OSV News) -- The Supreme Court June 13 unanimously dismissed a challenge to mifepristone, a pill commonly used for abortion, finding that the challengers lacked standing to bring the case. In a unanimous opinion written by Justice Brett Kavanaugh, the court found in FDA v. Alliance for Hippocratic Medicine that the 'plaintiffs lack Article III standing to challenge FDA's actions regarding the regulation of mifepristone.' 'Plaintiffs are pro-life, oppose elective abortion, and have

The Overseas Investment Office approved the sale of the land to McDonald's last month.

Winston & Strawn is offering its clients a lower-cost alternative to outsourced legal services that uses attorneys trained by the law firm for more routine legal tasks.

Poorly controlled cloud environments, growing access to systems, heightened regulatory scrutiny and significant deals activity will require healthcare CISOs, CIOs and other security leaders to bolster the defenses.

The Supreme Court heard oral arguments March 26 in a case concerning mifepristone, a pill commonly used for abortion.